Intensified alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Primary outcomes from the randomized phase III OL... by van Ommen-Nijhof, A., Steenbruggen, T.G., Wiersma, T.G., Balduzzi, S., Daletzakis, A., Holtkamp, M.J., Delfos, M., Schot, M., Beelen, K., Siemerink, E.J.M., Heijns, J., Mandjes, I.A., Wesseling, J., Rosenberg, E.H., Vrancken Peeters, M.J.T., Linn, S.C., Sonke, G.S.

Get full text

Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy by Beek, M.A, Tetteroo, E, Luiten, E.J.T, Gobardhan, P.D, Rutten, H.J.T, Heijns, J.B, Voogd, A.C, Klompenhouwer, E.G

Get full text

Development of an information standard for breast cancer in the Netherlands by Verloop, J., Klijn, F., van Vegchel, T., Bessems, M., Meeuwis, C., Wijers, L., Honkoop, A., Heijns, J., Siesling, S., Verbeek, X.

Get full text

Abstract P1-15-20: DIetary REstriction as an adjunct to neoadjuvant ChemoTherapy for HER2-negative breast cancer: Final results from the DIRECT trial (BOOG 2013-04) by de Groot, S, Lugtenberg, RT, Welters, MJ, Ehsan, I, Vreeswijk, MP, Smit, VT, de Graaf, H, Heijns, JB, Portielje, JE, van de Wouw, AJ, Imholz, AL, Kessels, LW, Vrijaldenhoven, S, Baars, A, Meershoek-Klein Kranenbarg, E, Duijm-de Carpentier, M, van Leeuwen-Stok, E, Putter, H, Longo, VD, van der Hoeven, JJ, Nortier, JW, Pijl, H, Kroep, JR

Get full text

Abstract P3-07-54: Insulin-like growth factor 1 receptor expression and polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: Results fro... by de Groot, S, Charehbili, A, van Laarhoven, HWM, Mooyaart, AL, Dekker-Ensink, NG, van de Ven, S, Janssen, LGM, Swen, JJ, Smit, VTHBM, Heijns, JB, Kessels, LW, van der Straaten, RJHM, Bhringer, S, Gelderblom, AJ, van der Hoeven, JJM, Guchelaar, HJ, Pijl, H, Kroep, JR

Get full text

Abstract P1-08-19: Changes in circulating vitamin D levels as a predictor for pathological response to neoadjuvant chemotherapy (NAC) in breast cancer (BC): A Dutch breast cancer t... by Charehbili, A, Hamdy, NAT, Smit, VTHBM, Liefers, G-J, Putter, H, Meershoek-Klein Kranenbarg, E, Heijns, JB, van Warmerdam, LJ, Kessels, LW, Dercksen, W, Pepels, MJ, Maartense, E, van Laarhoven, HWM, Vriens, B, van Leeuwen-Stok, E, van de Velde, CJH, Nortier, HWR, Kroep, JR

Get full text

Abstract P1-06-04: The predictive value of tumor-stroma ratio for radiological and pathological response to neoadjuvant chemotherapy in breast cancer (BC): A Dutch breast cancer tr... by Dekker, TJA, Charehbili, A, Smit, VTHBM, Wasser, MNJM, Heijns, JB, van Warmerdam, LJ, Kessels, L, Dercksen, W, Pepels, M, Maartense, E, van Laarhoven, HWM, Vriens, B, Meershoek-Klein Kranenbarg, E, van de Velde, CJH, Liefers, G-J, Nortier, HWR, Tollenaar, RAEM, Mesker, WE, Kroep, JR

Get full text

Abstract OT3-1-03: DIRECT: A phase II/III randomized trial with dietary restriction as an adjunct to neoadjuvant chemotherapy for HER2-negative breast cancer by de Groot, S, Vreeswijk, MPG, Smit, VTHBM, Heijns, JB, Imholz, ALT, Kessels, LW, Jager, A, Los, M, Weijl, NI, Smorenburg, CH, Portielje, JEA, Liefers, GJ, van de Velde, CJH, Meershoek, EM, van Leeuwen, E, Fischer, MJ, Kaptein, AA, Putter, H, Longo, V, Nortier, HWR, van der Hoeven, KJM, Pijl, H, Kroep, JR

Get full text

Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial by de Groot, Stefanie, Lugtenberg, Rieneke T., Cohen, Danielle, Welters, Marij J. P., Ehsan, Ilina, Vreeswijk, Maaike P. G., Smit, Vincent T. H. B. M., de Graaf, Hiltje, Heijns, Joan B., Portielje, Johanneke E. A., van de Wouw, Agnes J., Imholz, Alex L. T., Kessels, Lonneke W., Vrijaldenhoven, Suzan, Baars, Arnold, Kranenbarg, Elma Meershoek-Klein, Carpentier, Marjolijn Duijm-de, Putter, Hein, van der Hoeven, Jacobus J. M., Nortier, Johan W. R., Longo, Valter D., Pijl, Hanno, Kroep, Judith R.

Get full text

Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013–14)... by Lugtenberg, Rieneke T., de Groot, Stefanie, Kaptein, Ad A., Fischer, Maarten J., Kranenbarg, Elma Meershoek-Klein, Carpentier, Marjolijn Duijm-de, Cohen, Danielle, de Graaf, Hiltje, Heijns, Joan B., Portielje, Johanneke E. A., van de Wouw, Agnes J., Imholz, Alex L. T., Kessels, Lonneke W., Vrijaldenhoven, Suzan, Baars, Arnold, Fiocco, Marta, van der Hoeven, Jacobus J. M., Gelderblom, Hans, Longo, Valter D., Pijl, Hanno, Kroep, Judith R.

Get full text

Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study by Simons, Janine M., Jacobs, Julien G., Roijers, Joost P., Beek, Maarten A., Boonman-de Winter, Leandra J. M., Rijken, Arjen M., Gobardhan, Paul D., Wijsman, Jan H., Tetteroo, Eric, Heijns, Joan B., Yick, C. Y., Luiten, Ernest J. T.

Get full text

Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry by Geurts, Sandra M. E., Ibragimova, Khava I. E., Ding, Nan, Meegdes, Marissa, Erdkamp, Frans, Heijns, Joan B., Tol, Jolien, Vriens, Birgit E. P. J., Dercksen, Marcus W., Aaldering, Kirsten N. A., Pepels, Manon J. A. E., van de Winkel, Linda, Peters, Natascha A. J. B., van de Wouw, Agnes J., Maaskant, Sabrina A. J. G., Teeuwen-Dedroog, Nathalie J. A., van Nijnatten, Thiemo J. A., de Boer, Maaike, Tjan-Heijnen, Vivianne C. G.

Get full text

Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial... by de Groot, Stefanie, Pijl, Hanno, Charehbili, Ayoub, van de Ven, Saskia, Smit, Vincent T H B M, Meershoek-Klein Kranenbarg, Elma, Heijns, Joan B, van Warmerdam, Laurence J C, Kessels, Lonneke W, Dercksen, M Wouter, Pepels, Manon J A E, van Laarhoven, Hanneke W M, Vriens, Birgit E P J, Putter, Hein, Fiocco, Marta, Liefers, Gerrit-Jan, van der Hoeven, Jacobus J M, Nortier, Johan W R, Kroep, Judith R

Get full text

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial by Iwata, Hiroji, Chia, Stephen K L, Bashford, Anna, Inoue, Kenichi, Armstrong, Anne C, Wong, Alvin, Buyse, Marc, Harvey, Vernon, Smith, John W., Konstantinovic, Zora Neskovic, Rodriguez, Gladys I., Jáñez Martinez, Noelia, Knoop, Ann Soegaard, De Boer, Richard Hendry, Rai, Yoshiaki, Yamamoto, Naohito, Brincat, Stephen, Papish, Steven William, Manalo, Yvonne, Sorensen, Peter Grundtvig, Aogi, Kenjiro, Shimizu, Satoru, Mainwaring, Paul, Chang, Jose, del Barco Berron, Sonia, Dickerson, Laura C., Klein, Leonard M., Ruxer, Robert, Veyret, Corinne, Wagnerova, Maria, Richards, Donald A., Vasileios, Asskikis, Dourthe, Louis Marie, Lu, Yen-Shen, Greenspan, Andrew R., Gonzalez Santiago, Santiago, Perren, Timothy John, Yau, Chung Cheung Thomas, Pikó, Béla, Sato, Nobuaki, Askoy, Sercan, Altundag, Mustafa Kadri, Saip, Pinar, Bajaj, Rajesh, Vestlev, Peter Michael, Dank, Magdolna, Cinieri, Saverio, Suszko-Kazarnowicz, Malgorzata, Yap, Yoon Sim, Chen, Shin-Cheh, Haley, Barbara Bacsik, Inhorn, Roger C., Koynova, Tatyana, Schneeweiss, Andreas, Cubedo Cervera, Ricardo, Urruticoechea Ribate, Ander, Schwartz, Garry H., Mocharnuk, Robert Scott, Alkhouri, Nabiel, Erickson, Nicholette, Traynor, Ann, Volterra, Fabio, Capo, Gerardo, Flaherty, Lawrence E., Baidas, Said, Lybaert, Willem, Holland, David R., Gonzalez Jimenez, Sonia, Vanlemmens, Laurence, Ruggeri, Enzo Maria, Desai, Ajit, Nixon, David Allen, O'Brien, Edward, Lanier, Keith S., Brescia, Frankie Ann, Richard, Vincent, Geldhof, Kurt, Bednarik, Otakar, Schwedler, Kathrin, Fries, Stefan, Klare, Peter, Griesinger, Frank, Trufflandier, Nathalie, Chetiyawardana, Anula D., Papandreou, Christos, Hornyak, Lajos, Simo, Erzsebet, Im, Seock-Ah, Ruit, Jan B., Ciltas, Aydin, Benekli, Mustafa, Conkright, William A., Ottaviano, Yvonne, Delmas, Andrew, Steele, Heather A., Bova, Abby R., Shirinian, Mihran, O'Rourke, Timothy J., Francisco, Michael, Carrillo Flores, Maria Regina

Get full text

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry by Ibragimova, Khava I. E., Geurts, Sandra M. E., Meegdes, Marissa, Erdkamp, Frans, Heijns, Joan B., Tol, Jolien, Vriens, Birgit E. P. J., Dercksen, Marcus W., Aaldering, Kirsten N. A., Pepels, Manon J. A. E., van de Winkel, Linda, Peters, Natascha A. J. B., Teeuwen-Dedroog, Nathalie J. A., Vriens, Ingeborg J. H., Tjan-Heijnen, Vivianne C. G.

Get full text

The prognostic impact of BMI in patients with HR+/HER2− advanced breast cancer: a study of the SONABRE registry by Lammers, Senna W. M., Thurisch, Hannah, Vriens, Ingeborg J. H., Meegdes, Marissa, Engelen, Sanne M. E., Erdkamp, Frans L. G., Dercksen, M. Wouter, Vriens, Birgit E. P. J., Aaldering, Kirsten N. A., Pepels, Manon J. A. E., van de Winkel, Linda M. H., Peters, Natascha A. J. B., Tol, Jolien, Heijns, Joan B., van de Wouw, Agnes J., Teeuwen, Nathalie J. A., Geurts, Sandra M. E., Tjan-Heijnen, Vivianne C. G.

Get full text

Quantification of ribociclib in dried blood spots by LC–MS/MS: Method development and clinical validation by Braal, C. Louwrens, Lam, Mei H., Rienks, Tineke, van Tilborg, Claudia J., Heuts, Wendy, Heijns, Joan B., Bos, Monique E.M.M., Mathijssen, Ron H.J., de Bruijn, Peter, Koolen, Stijn L.W.

Get full text

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry by Meegdes, Marissa, Ibragimova, Khava I. E., Lobbezoo, Dorien J. A., Vriens, Ingeborg J. H., Kooreman, Loes F. S., Erdkamp, Frans L. G., Dercksen, M. Wouter, Vriens, Birgit E. P. J., Aaldering, Kirsten N. A., Pepels, Manon J. A. E., van de Winkel, Linda M. H., Tol, Jolien, Heijns, Joan B., van de Wouw, Agnes J., Peters, Natascha A. J. B., Hochstenbach-Waelen, Ananda, Smidt, Marjolein L., Geurts, Sandra M. E., Tjan-Heijnen, Vivianne C. G.

Get full text

Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry by Ibragimova, Khava I. E., Geurts, Sandra M. E., Croes, Sander, Erdkamp, Frans, Heijns, Joan B., Tol, Jolien, Vriens, Birgit E. P. J., Aaldering, Kirsten N. A., Dercksen, Marcus W., Pepels, Manon J. A. E., Peters, Natascha A. J. B., van de Winkel, Linda, Tilli, Dominique J. P., Vriens, Ingeborg J. H., de Boer, Maaike, Tjan-Heijnen, Vivianne C. G.

Get full text

Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry by Ibragimova, Khava I.E., Geurts, Sandra M.E., Laczkó, Dávid, Meegdes, Marissa, Erdkamp, Frans, Heijns, Joan B., Tol, Jolien, Vriens, Birgit E.P.J., Aaldering, Kirsten N.A., Dercksen, Marcus W., Pepels, Manon J.A.E., Peters, Natascha A.J.B., van de Winkel, Linda M.H., van de Wouw, Agnes J., de Fallois, Aude, van Kats, Maartje A.C.E., Tjan-Heijnen, Vivianne C.G.

Get full text